Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ... Neurology 97 (19), e1870-e1885, 2021 | 240 | 2021 |
Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome NA Stearns, LR Schaevitz, H Bowling, N Nag, UV Berger, ... Neuroscience 146 (3), 907-921, 2007 | 229 | 2007 |
Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome N Nag, JE Berger-Sweeney Neurobiology of disease 26 (2), 473-480, 2007 | 123 | 2007 |
Reduced extinction of hippocampal-dependent memories in CPEB knockout mice J Berger-Sweeney, NR Zearfoss, JD Richter Learning & memory 13 (1), 4-7, 2006 | 121 | 2006 |
Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp21lox mice N Nag, JM Moriuchi, CGK Peitzman, BC Ward, NH Kolodny, ... Behavioural Brain Research 196 (1), 44-48, 2009 | 105 | 2009 |
Visualization of functionally activated circuitry in the brain Y Wilson, N Nag, P Davern, BJ Oldfield, MJ McKinley, U Greferath, ... Proceedings of the National Academy of Sciences 99 (5), 3252-3257, 2002 | 83 | 2002 |
Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome N Nag, TJ Mellott, JE Berger-Sweeney Brain research 1237, 101-109, 2008 | 79 | 2008 |
Cognitive and social functions and growth factors in a mouse model of Rett syndrome LR Schaevitz, JM Moriuchi, N Nag, TJ Mellot, J Berger-Sweeney Physiology & behavior 100 (3), 255-263, 2010 | 78 | 2010 |
Neurochemical changes in a mouse model of Rett syndrome: changes over time and in response to perinatal choline nutritional supplementation BC Ward, NH Kolodny, N Nag, JE Berger‐Sweeney Journal of neurochemistry 108 (2), 361-371, 2009 | 65 | 2009 |
Updated results of the COVID-19 in MS global data sharing initiative: anti-CD20 and other risk factors associated with COVID-19 severity S Simpson-Yap, A Pirmani, T Kalincik, E De Brouwer, L Geys, T Parciak, ... Neurology: Neuroimmunology & Neuroinflammation 9 (6), e200021, 2022 | 41 | 2022 |
Development of an international prostate cancer outcomes registry SM Evans, N Nag, D Roder, A Brooks, J L Millar, KL Moretti, D Pryor, ... BJU international 117, 60-67, 2016 | 40 | 2016 |
A narrative review of lifestyle factors associated with Parkinson’s disease risk and progression N Nag, GA Jelinek Neurodegenerative Diseases 19 (2), 51-59, 2019 | 34 | 2019 |
Development of indicators to assess quality of care for prostate cancer N Nag, J Millar, ID Davis, S Costello, JB Duthie, S Mark, W Delprado, ... European urology focus 4 (1), 57-63, 2018 | 31 | 2018 |
Depression mediates the relationship between fatigue and mental health-related quality of life in multiple sclerosis A Fidao, A De Livera, N Nag, S Neate, GA Jelinek, S Simpson-Yap Multiple sclerosis and related disorders 47, 102620, 2021 | 30 | 2021 |
The role of angiotensin II/AT1 receptor signaling in regulating retinal microglial activation JA Phipps, KA Vessey, A Brandli, N Nag, MX Tran, AI Jobling, EL Fletcher Investigative Ophthalmology & Visual Science 59 (1), 487-498, 2018 | 27 | 2018 |
Higher‐quality diet and non‐consumption of meat are associated with less self‐determined disability progression in people with multiple sclerosis: A longitudinal cohort study S Simpson‐Yap, N Nag, Y Probst, G Jelinek, S Neate European Journal of Neurology 29 (1), 225-236, 2022 | 24 | 2022 |
Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1 N Nag, V Tarlac, E Storey The Cerebellum 12, 74-82, 2013 | 22 | 2013 |
Tracing functional circuits using c-Fos regulated expression of marker genes targeted to neuronal projections M Murphy, U Greferath, N Nag, J Nithianantharajah, YM Wilson Front Biosci 9 (40), l, 2004 | 22 | 2004 |
Experiences of and attitudes to lifestyle modification for the management of multiple sclerosis: A qualitative analysis of free‐text survey data SL Neate, A Donald, GA Jelinek, N Nag Health Expectations 25 (1), 214-222, 2022 | 18 | 2022 |
Fos-tau-LacZ mice expose light-activated pathways in the visual system U Greferath, N Nag, AJ Zele, BV Bui, Y Wilson, AJ Vingrys, M Murphy Neuroimage 23 (3), 1027-1038, 2004 | 18 | 2004 |